Alnylam Pharmaceuticals, Inc.

STATE OF WISCONSIN INVESTMENT BOARD ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

66,065

Value ($000)

26,271

Weight

0.1%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	26,271	0.1%	66,065	12/31/2025
2025 Q3	11/14/2025	31,249	0.1%	68,529	9/30/2025
2025 Q2	8/14/2025	25,470	0.1%	78,106	6/30/2025
2025 Q1	5/15/2025	19,753	0.1%	73,155	3/31/2025
2024 Q4	2/14/2025	18,442	0.0%	78,375	12/31/2024
2024 Q3	11/14/2024	21,753	0.1%	79,094	9/30/2024
2024 Q2	8/14/2024	18,938	0.1%	77,936	6/30/2024
2024 Q1	5/14/2024	10,269	0.0%	68,714	3/31/2024
2023 Q4	2/12/2024	38,370	0.1%	200,460	12/31/2023
2023 Q3	11/14/2023	35,757	0.1%	201,905	9/30/2023
2023 Q2	8/14/2023	42,015	0.1%	221,204	6/30/2023
2023 Q1	5/15/2023	36,620	0.1%	182,807	3/31/2023
2022 Q4	2/14/2023	20,303	0.1%	85,434	12/31/2022
2022 Q3	11/14/2022	18,088	0.1%	90,369	9/30/2022
2022 Q2	8/15/2022	35,234	0.1%	241,577	6/30/2022
2022 Q1	5/13/2022	19,190	0.0%	117,519	3/31/2022
2021 Q4	2/11/2022	15,805	0.0%	93,201	12/31/2021
2021 Q3	11/12/2021	18,766	0.0%	99,390	9/30/2021
2021 Q2	8/12/2021	19,517	0.0%	115,132	6/30/2021
2021 Q1	5/17/2021	17,205	0.0%	121,857	3/31/2021
2020 Q4	2/3/2021	23,890	0.1%	183,809	12/31/2020
2020 Q3	11/16/2020	27,446	0.1%	188,504	9/30/2020
2020 Q2	8/12/2020	20,958	0.1%	141,504	6/30/2020
2020 Q1	5/6/2020	14,770	0.0%	135,694	3/31/2020
2019 Q4	2/14/2020	16,050	0.0%	139,363	12/31/2019